Official Journal of the Italian Society of Orthopaedics and Traumatology
Thirty-day follow-up | Pertrochanteric | Subtrochanteric | OR (95% CI)/p |
---|---|---|---|
Alive at 30-day follow-up | 92.1% | 91.0% | 1.148 (0.960–1.374)/0.130 |
No weight bearing within 30 days post-operation* | 8.9% | 22.3% | 0.338 (0.256–0.445)/< 0.001 |
Post-FX mobility (30 days)* | 6.66 ± 2.67 | 7.33 ± 2.71 | < 0.001 |
Pre-FX versus post-FX mobility (30 days)* | 2.88 ± 2.69 | 3.72 ± 2.98 | < 0.001 |
Living at own home after 30 days* | 48.3% | 44.8% | 0.864 (0.775–0.962)/0.008 |
Living in own home pre-fracture but at healthcare facility after 30 days* | 38.0% | 44.5% | < 0.001 |
Bone-protective treatment: | 42.5% | 42.3% | 1.009 (0.905–1.124)/0.887 |
Anti-resorptive | 39.7% | 38.7% | 1.046 (0.938–1.168)/0.419 |
Bone forming* | 3.6% | 4.8% | 0.747 (0.578–0.965)/0.025 |
Hospital re-admission within 30 days post-operation | 3.1% | 2.5% | 1.206 (0.869–1.673)/0.263 |
Re-operation < 30 days post-operation* | 1.7% | 1.9% | 0.011 |
Wound surgical revision* | 0.5% | 1.1% | 2.418 (1.413–4.137)/0.001 |
Hip arthroplasty dislocation | 0.2% | 0.1% | |
Failed fixation | 0.7% | 0.4% | |
Peri-implant fracture | 0.1% | 0.2% | |
Other reasons | 0.2% | 0.1% |